Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use … [Read more...]
Genetic Testing
New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations
February 21, 2021
Emerging Tests
New Genomic Test Can Eliminate Up to One-Third of Medically Unnecessary Prostate Cancer Biopsies
February 21, 2021
Genetic testing has been shown to be effective in detecting prostate cancer and eliminating the need for unnecessary biopsies. And even though the current commercial market for such tests is crowded, … [Read more...]
Genetic Testing
New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations
February 11, 2021
Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use … [Read more...]
The Quest Case and Medical Malpractice Liability Risks of Genetic Testing Labs
January 6, 2021
For years, Quest Diagnostics has been embroiled in a poignant lawsuit testing the liability of genetic labs for faulty DNA test results. In 2018, Quest struck a decisive blow by getting the South … [Read more...]
Genetic Testing
The Quest Case and Medical Malpractice Liability Risks of Genetic Testing Labs
November 27, 2020
For years, Quest Diagnostics has been embroiled in a poignant lawsuit testing the liability of genetic labs for faulty DNA test results. In 2018, Quest struck a decisive blow by getting the South … [Read more...]
Genetic Testing
New EMSO Guidelines Address Efficacy of Next Generation Sequencing for Different Cancer Types
November 2, 2020
The European Society for Medical Oncology (ESMO) recently issued guidelines on use of next-generation sequencing (NGS) for various types of cancer as part of routine clinical practice. The … [Read more...]
Data
Genomic Testing Utilization Is Low & Geographically Inconsistent but Not Just Due to Payor Coverage
October 8, 2020
Genomic testing is inconsistently utilized in the U.S., even in states with favorable coverage policies. Those are the findings of a report from the Personalized Medicine Coalition (PMC) released in … [Read more...]
Genetic Tests
New Guidelines Advise Against Using Polygenetic Risk Scores for Routine Patient Management
September 22, 2020
New guidelines from the National Comprehensive Cancer Network (NCCN) advise against using polygenetic risk scores for routine patient management and update previous recommendations for assessing … [Read more...]
Precision Medicine
New ACOG Guidelines Recommend cfDNA-Based NIPT for All Pregnancies, Not Just Risky Ones
August 29, 2020
The American College of Obstetricians and Gynecologists (ACOG) has revised its position on noninvasive prenatal testing (NIPT) and is now recommending prenatal aneuploidy screening for all pregnant … [Read more...]
Reimbursement
Payors Gradually Increasing Coverage of Liquid Biopsies but Obstacles Remain
July 28, 2020
Gaining the acceptance of insurers and payors for new tests and testing technology is a perennial challenge for laboratories and test developers. This has been especially true with liquid biopsy … [Read more...]
